Viewing Study NCT02040220


Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2026-02-25 @ 8:31 PM
Study NCT ID: NCT02040220
Status: COMPLETED
Last Update Posted: 2019-04-10
First Post: 2014-01-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Eylea for Central Retinal Vein Occlusion (CRVO)
Sponsor: Bayer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Retinal Vein Occlusion View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CRVO, Macular edema, Aflibercept, anti-VEGF View